DHR vs TSLA: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and Tesla, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-06-20.
Danaher Corporation · Healthcare
$177.17
+8.9% upside to fair value
Grade B
High Quality
VS
Tesla, Inc. · Consumer Cyclical
$400.49
-1.1% upside to fair value
Grade D
QuantHub Verdict
DHR has more upside to fair value
(+8.9%).
DHR trades at a lower forward P/E
(34.1x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
TSLA |
| Current Price |
$177.17 |
$400.49 |
| Fair Value Estimate |
$192.90 |
$396.15 |
| Upside to Fair Value |
+8.9%
|
-1.1%
|
| Market Cap |
$125.4B |
$1,504.1B |
| Forward P/E |
34.1x
|
334.1x
|
| EV / EBITDA |
20.8x
|
124.0x
|
| Price / Sales |
5.1x
|
15.4x
|
| Price / FCF |
23.7x
|
214.9x
|
| Revenue Growth YoY |
+3.7%
|
+15.8%
|
| Gross Margin |
60.7%
|
19.1%
|
| Operating Margin |
21.0%
|
5.0%
|
| Return on Equity |
7.1%
|
4.8%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
4.22%
|
0.47%
|
| Analyst Consensus |
Strong Buy
|
Buy
|
Investment Thesis
Danaher Corporation operates in the healthcare sector, specializing in medical diagnostics and research tools through three balanced platforms: Biotechnology, Life Sciences, and Diagnostics. The company benefits from a durable competitive moat supported by the Danaher Business System, disciplined capital allocation, and a platform-centric organizational structure. Despite modest revenue growth of…
Tesla, Inc. is a leading global electric vehicle manufacturer and energy solutions provider, led by CEO Elon Musk since 2008. The company maintains a strong position in the EV market with a unique fast-charging and software ecosystem, although its EV market share is declining amid intensifying competition. Tesla's business quality is medium due to its narrowing moat and modest profitability, with…
Accumulation Zones
| Metric |
DHR |
TSLA |
| Zone Low |
$144.68 |
$297.11 |
| Zone High |
$163.97 |
$336.73 |
| In Buy Zone? |
No
|
No
|